GoodRx Holdings (GDRX) Non-Current Assets (2019 - 2026)

GoodRx Holdings has disclosed Non-Current Assets across 8 years of filings, most recently posting $743.6 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 3.19% year-over-year to $743.6 million; the TTM figure through Jun 2026 stood at $3.0 billion (up 1.32% YoY), while the FY2025 annual figure was $761.0 million, up 4.41% from the prior year.
• Non-Current Assets came in at $743.6 million for Q2 2026 at GoodRx Holdings, down from $754.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $772.8 million in Q2 2023 to a low of $543.6 million in Q1 2022.
• Average Non-Current Assets over 5 years is $721.8 million, with a median of $728.4 million recorded in 2024.
• Year-over-year, Non-Current Assets surged 40.25% in 2022 and dropped 6.21% in 2024.
• Over 5 years, Non-Current Assets stood at $684.9 million in 2022, then climbed by 4.54% to $716.0 million in 2023, then advanced by 1.79% to $728.8 million in 2024, then grew by 4.41% to $761.0 million in 2025, then retreated by 2.28% to $743.6 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $743.6 million in Q2 2026, $754.8 million in Q1 2026, and $761.0 million in Q4 2025.